Overview
- 262 inspections across 203 sites are on record.
- 153 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-04-23.
At a glance
Inspections
262
Sites
203
Observations
153
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| George H. Freeman, M.D. | 23 Apr 2021 | Biologics | |
| Daiichi Sankyo, Inc. | 30 Mar 2021 | Human Drugs | |
| Bindu Balani, M.D. | 2 Mar 2021 | Human Drugs | |
| Pfizer Inc. | 8 Jan 2021 | Human Drugs | |
| David S. Siegel, M.D. | 2 Nov 2020 | Biologics |
Sites inspected
George H. Freeman, M.D.Newport News, United States1 insp.
Daiichi Sankyo, Inc.Basking Ridge, United States1 insp.
Bindu Balani, M.D.Hackensack, United States1 insp.
Pfizer Inc.Groton, United States1 insp.
David S. Siegel, M.D.Hackensack, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nina Yang9 shared
Krystal O Ogunremi4 shared
Michael Serrano3 shared
Christina N Maurino3 shared
Himanshu Gupta2 shared
Nicole C Victoria2 shared
Lauren C Iacono-Connors2 shared
Jean M Mulinde2 shared
Sam H Haidar2 shared
Xiaohan Cai1 shared
Full investigator report
Get the verbatim findings behind Peter R Lenahan's 153 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site